Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2025)
Insight Molecular Diagnostics (IMDX) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.12 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio rose 225.71% to 0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12 through Dec 2025, up 225.71% year-over-year, with the annual reading at 0.13 for FY2025, 289.69% up from the prior year.
- Asset Utilization Ratio hit 0.12 in Q4 2025 for Insight Molecular Diagnostics, up from 0.09 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.12 in Q4 2025 to a low of 0.01 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.03 in 2021.
- Biggest five-year swings in Asset Utilization Ratio: tumbled 84.21% in 2022 and later surged 852.71% in 2025.
- Year by year, Asset Utilization Ratio stood at 0.05 in 2021, then crashed by 84.21% to 0.01 in 2022, then surged by 158.11% to 0.02 in 2023, then soared by 85.98% to 0.04 in 2024, then skyrocketed by 225.71% to 0.12 in 2025.
- Business Quant data shows Asset Utilization Ratio for IMDX at 0.12 in Q4 2025, 0.09 in Q3 2025, and 0.08 in Q2 2025.